Fresenius Medical Care AG
XMUN:FME
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (24.4), the stock would be worth €57.24 (45% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.8 | €39.38 |
0%
|
| 3-Year Average | 24.4 | €57.24 |
+45%
|
| 5-Year Average | 24.4 | €57.17 |
+45%
|
| Industry Average | 16.2 | €37.94 |
-4%
|
| Country Average | 15.5 | €36.43 |
-7%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
€29.9B
|
/ |
Jan 2026
€1.8B
|
= |
|
|
€29.9B
|
/ |
Dec 2026
€2.2B
|
= |
|
|
€29.9B
|
/ |
Dec 2027
€2.4B
|
= |
|
|
€29.9B
|
/ |
Dec 2028
€2.8B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 16.8 | 23.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD | 14 | 54.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 9.8 | 13.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.4B USD | 0 | 11.8 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR | 14.6 | 20.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22B USD | 16.7 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 17.3 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 10 | 11.4 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.2B USD | -26.2 | -26.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 9.8 | 13.8 | |
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
10.5B AUD | 15.4 | 19.4 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 10.6 |
| Median | 15.5 |
| 70th Percentile | 23.1 |
| Max | 672.9 |
Other Multiples
Fresenius Medical Care AG
Glance View
Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.